Rambam Health Care Campus (Rambam), in collaboration with ynet and Calcalist, recently hosted the Rambam–Medicine of Tomorrow conference, where medical innovation and artificial intelligence took center stage.
On Wednesday, October 14, 2026, the first event of the annual Rambam Summit took place in the recently opened Helmsley Health Discovery Tower, bringing together technology leaders, academics, entrepreneurs, physicians, and scientists to discuss the challenges and opportunities shaping the future of medicine.
“The future of medicine is being built today, at the intersection of medical excellence, groundbreaking research, and new technologies. At the Rambam Tomorrow conference, we discussed how needs identified at the bedside can lead to solutions that influence medicine and patient care,” says Dr. Michal Mekel, Rambam’s Director General. “Our aim is to encourage dialogue and connections among medical professionals, scientists, and entrepreneurs to advance solutions that improve the quality of care, enable personalized medicine, and shape tomorrow’s health care system. At Rambam, innovation is more than a vision for the future; it is an integral part of our daily work.”
The conference featured interviews with leading experts in industry and health care s including Dr. Michal Mekel, Michael Kagan, Chief Technology Officer of NVIDIA; Maor Shlomo, founder of the Base44 platform and Managing Partner at Second Light, each sharing their perspective on the future of medicine.
The first panel explored the opportunities and risks of integrating artificial intelligence into medicine. Panelists included Tomer Ofir, Public Sector Healthcare Lead at AWS Israel; Professor Shahar Shelly, Director of Rambam’s Department of Neurology and Head of the Laboratory for Artificial Intelligence and Decision-Making at the Technion-Israel Institute of Technology; Professor Talya Miron-Shatz, a researcher in medical decision-making at Ono Academic College and CEO of Buddy&Soul; and Hagar Trau, Chief Information Officer at Rambam.
The second panel examined what the next drug discovery might look like in an era of innovation and technology. Participants included Professor Lior Gepstein, Director of Rambam’s Department of Cardiology and Director of the Division of Research; Dr. Dana Bar-On, Senior Director and Head of Academic and Research Partnerships at Teva Pharmaceuticals; and Dr. Moshik Cohen-Kutner, Co-founder and CEO of Omnix Medical.
The next panel focused on entrepreneurship and the development of breakthrough health care products, featuring Michael Braginsky, Co-founder and Chief Technology Officer of Aidoc; Professor Rafi Beyar, President of Rambam’s International Friends Associations and Managing Partner at ALIVE Israel HealthTech Fund; and Dr. Eyal Zadicario, COO and General Manager of Insightec Israel.
The last panel discussion focused on medical information as a strategic asset and the question of ownership. Panelists included Lior Bonfis, Vice President of Operations at Philips Global and President and CEO of Philips Israel; Dr. Michal Tzuchman-Katz, Vice President of Innovation and Research at Maccabi Healthcare Services; and Professor Danny Eytan, Director of the Wagner-Green Pediatric Intensive Care Unit at Rambam’s Ruth Rappaport Children’s Hospital and a researcher at the Technion.
The conference also included TED-style talks on practical medical innovation. Professor Irit Ben-Aharon, Director of Rambam’s Joseph Fishman Oncology Center and Senior Vice Dean of the Technion’s Ruth & Bruce Rappaport Faculty of Medicine, presented a new paradigm in oncology. Dr. Yona Vaisbuch, Rambam’s Deputy Director for Transformation and Clinical Operations, discussed the introduction of new technologies into hospitals. Professor Iyad Khamaysi, Director of the Advanced Endoscopy Unit at Rambam’s Gastroenterology Institute and Director of the hospital’s Liora & Levy Gerzberg Family Foundation Innovation Laboratory, spoke about using advanced tools for biopsies. Dr. Dana Baron-Shahaf, Director of the Neurosurgical Anesthesia Unit, presented her invention, which gently awakens the brain and opens up new rehabilitation possibilities for unconscious patients.
It was a fascinating day of glimpses into the medicine of TOMORROW and how it is taking shape TODAY.
